Mersifarma Tirmaku Mercusana

PT Mersifarma Tirmaku Mercusana is a prominent Indonesian pharmaceutical company that specializes in the development, production, and marketing of high-quality ethical and generic medicines. Established in 1997, the company has built a strong reputation as a leader in the central nervous system (CNS) therapeutic segment, particularly in psychotropic and neurological medications. Mersifarma operates a sophisticated manufacturing facility in Sukabumi, West Java, which features dedicated production lines for specialized drug classes such as cephalosporins and psychotropics, all compliant with Good Manufacturing Practices (GMP). Their extensive product portfolio serves various medical fields including psychiatry, neurology, internal medicine, and cardiology. The company is committed to improving public health in Indonesia by providing affordable access to essential medications and maintaining rigorous quality standards.